SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 12 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,787,000 | +16.6% | 150,000 | 0.0% | 0.07% | +3.1% |
| Q2 2018 | $1,532,000 | -21.3% | 150,000 | 0.0% | 0.06% | -29.7% |
| Q1 2018 | $1,947,000 | +33.4% | 150,000 | 0.0% | 0.09% | +19.7% |
| Q4 2017 | $1,460,000 | -33.9% | 150,000 | 0.0% | 0.08% | -39.2% |
| Q3 2017 | $2,208,000 | -8.5% | 150,000 | 0.0% | 0.12% | -16.7% |
| Q2 2017 | $2,414,000 | +1.0% | 150,000 | 0.0% | 0.15% | -5.1% |
| Q1 2017 | $2,390,000 | +31.0% | 150,000 | 0.0% | 0.16% | +32.8% |
| Q4 2016 | $1,824,000 | -12.3% | 150,000 | 0.0% | 0.12% | -6.3% |
| Q3 2016 | $2,081,000 | -23.6% | 150,000 | 0.0% | 0.13% | -24.0% |
| Q2 2016 | $2,723,000 | – | 150,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |